Although there is limited evidence regarding the relationship between ARNi use and haemoglobin concentration, the literature suggests that similar to other medications inhibiting the renin-angiotensin system, ARNi could join other existing factors in HF patients for the development of anaemia. The gene discussed is REN; the disease is anemia (phenotype).